Malaria is a major public health burden throughout the world. Resistance to the antimalarial
drugs has increased the mortality and morbidity rate that is achieved so far through the …

New developments in Plasmodium vivax malaria: severe disease... : Current Opinion in
Infectious Diseases New developments in Plasmodium vivax malaria: severe disease and the …

Plasmodium vivax is the most geographically widespread cause of human malaria and is
responsible for the majority of cases outside of the African continent. While great progress …

The diagnosis and treatment of Plasmodium vivax malaria differs from that of Plasmodium
falciparum malaria in fundamentally important ways. This article reviews the guiding …

Ethiopia has the greatest burden of Plasmodium vivax in Africa, but little is known about the
epidemiological landscape of parasites across the country. We analysed the genomic …

Abstract Background Increased resistance by Plasmodium falciparum parasites led to the
withdrawal of the antimalarial drugs chloroquine and sulphadoxine-pyrimethamine in …

This review article aims to investigate the genotypic profiles of Plasmodium falciparum and
Plasmodium vivax isolates collected across a wide geographic region and their association …

Abstract The Asia–Pacific region faces formidable challenges in achieving malaria
elimination by the proposed target in 2030. Molecular surveillance of Plasmodium parasites …

In this review we present recent developments in the analysis of Plasmodium vivax clinical
trials and ex vivo drug-susceptibility assays, as well approaches currently being used to …

The lack of a long-term in vitro culture method has severely restricted the study of
Plasmodium vivax, in part because it limits genetic manipulation and reverse genetics. We …